0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biological Small-Caliber Artificial Blood Vessel Market Research Report 2026
Published Date: 2026-03-20
|
Report Code: QYRE-Auto-14E17687
Home | Market Reports | Health| Medical Devices & Equipment
Global Biological Small Caliber Artificial Blood Vessel Market Research Report 2024
BUY CHAPTERS

Global Biological Small-Caliber Artificial Blood Vessel Market Research Report 2026

Code: QYRE-Auto-14E17687
Report
2026-03-20
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Biological Small-Caliber Artificial Blood Vessel Market

The global Biological Small-Caliber Artificial Blood Vessel market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Biological Small-Caliber Artificial Blood Vessel competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Bio-type small-caliber artificial blood vessels are medical devices made of biomaterials and used to replace or repair blood vessels with smaller diameters (usually less than 6 mm in diameter). These blood vessels are made of natural biomaterials or decellularized animal tissues, which can integrate well with human tissues, reduce immune rejection, and promote the regeneration and repair of new blood vessels. Bio-type small-caliber artificial blood vessels are widely used in the fields of cardiovascular disease treatment and vascular injury repair, providing higher biocompatibility and long-term functionality.
Biological small-caliber artificial blood vessels represent a major advancement in the field of cardiovascular disease and vascular injury repair. By using natural biomaterials or decellularized animal tissues, these blood vessels can significantly improve compatibility with human tissues, reduce immune rejection, and promote the migration and regeneration of their own cells. Compared with traditional synthetic blood vessels, biological small-caliber artificial blood vessels are not only closer to natural blood vessels in function, but also reduce the incidence of complications and provide a longer service life. Therefore, biological small-caliber artificial blood vessels have a very broad prospect in clinical applications, especially in meeting the needs of small-diameter blood vessel replacement, showing excellent potential and effect.
This report delivers a comprehensive overview of the global Biological Small-Caliber Artificial Blood Vessel market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Biological Small-Caliber Artificial Blood Vessel. The Biological Small-Caliber Artificial Blood Vessel market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Biological Small-Caliber Artificial Blood Vessel market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Biological Small-Caliber Artificial Blood Vessel manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Biological Small-Caliber Artificial Blood Vessel Market Report

Report Metric Details
Report Name Biological Small-Caliber Artificial Blood Vessel Market
Segment by Type
  • Autologous Cell-Derived Blood Vessels
  • Blood Vessels Derived From Non-Autologous Cells
  • Others
by Application
  • General Hospital
  • Specialized Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gore Medical, Terumo Corporation, Maquet, CryoLife, LeMaitre Vascular, Cook Medical, Boston Scientific, Medtronic
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Biological Small-Caliber Artificial Blood Vessel manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Biological Small-Caliber Artificial Blood Vessel sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Biological Small-Caliber Artificial Blood Vessel Market report?

Ans: The main players in the Biological Small-Caliber Artificial Blood Vessel Market are Gore Medical, Terumo Corporation, Maquet, CryoLife, LeMaitre Vascular, Cook Medical, Boston Scientific, Medtronic

What are the Application segmentation covered in the Biological Small-Caliber Artificial Blood Vessel Market report?

Ans: The Applications covered in the Biological Small-Caliber Artificial Blood Vessel Market report are General Hospital, Specialized Hospital, Others

What are the Type segmentation covered in the Biological Small-Caliber Artificial Blood Vessel Market report?

Ans: The Types covered in the Biological Small-Caliber Artificial Blood Vessel Market report are Autologous Cell-Derived Blood Vessels, Blood Vessels Derived From Non-Autologous Cells, Others

1 Biological Small-Caliber Artificial Blood Vessel Market Overview
1.1 Product Definition
1.2 Biological Small-Caliber Artificial Blood Vessel by Type
1.2.1 Global Biological Small-Caliber Artificial Blood Vessel Market Value by Type: 2025 vs 2032
1.2.2 Autologous Cell-Derived Blood Vessels
1.2.3 Blood Vessels Derived From Non-Autologous Cells
1.2.4 Others
1.3 Biological Small-Caliber Artificial Blood Vessel by Application
1.3.1 Global Biological Small-Caliber Artificial Blood Vessel Market Value by Application: 2025 vs 2032
1.3.2 General Hospital
1.3.3 Specialized Hospital
1.3.4 Others
1.4 Global Biological Small-Caliber Artificial Blood Vessel Market Size Estimates and Forecasts
1.4.1 Global Biological Small-Caliber Artificial Blood Vessel Revenue 2021–2032
1.4.2 Global Biological Small-Caliber Artificial Blood Vessel Sales 2021–2032
1.4.3 Global Biological Small-Caliber Artificial Blood Vessel Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Biological Small-Caliber Artificial Blood Vessel Market Competition by Manufacturers
2.1 Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Manufacturers (2021–2026)
2.2 Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Biological Small-Caliber Artificial Blood Vessel Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Biological Small-Caliber Artificial Blood Vessel, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Biological Small-Caliber Artificial Blood Vessel, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Biological Small-Caliber Artificial Blood Vessel, Product Types and Applications
2.7 Global Key Manufacturers of Biological Small-Caliber Artificial Blood Vessel, Date of Entry into the Industry
2.8 Global Biological Small-Caliber Artificial Blood Vessel Market Competitive Situation and Trends
2.8.1 Global Biological Small-Caliber Artificial Blood Vessel Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Biological Small-Caliber Artificial Blood Vessel Players Market Share by Revenue
2.8.3 Global Biological Small-Caliber Artificial Blood Vessel Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Biological Small-Caliber Artificial Blood Vessel Market Scenario by Region
3.1 Global Biological Small-Caliber Artificial Blood Vessel Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Biological Small-Caliber Artificial Blood Vessel Sales by Region: 2021–2032
3.2.1 Global Biological Small-Caliber Artificial Blood Vessel Sales by Region: 2021–2026
3.2.2 Global Biological Small-Caliber Artificial Blood Vessel Sales by Region: 2027–2032
3.3 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Region: 2021–2032
3.3.1 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Region: 2021–2026
3.3.2 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Region: 2027–2032
3.4 North America Biological Small-Caliber Artificial Blood Vessel Market Facts & Figures by Country
3.4.1 North America Biological Small-Caliber Artificial Blood Vessel Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Biological Small-Caliber Artificial Blood Vessel Sales by Country (2021–2032)
3.4.3 North America Biological Small-Caliber Artificial Blood Vessel Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Biological Small-Caliber Artificial Blood Vessel Market Facts & Figures by Country
3.5.1 Europe Biological Small-Caliber Artificial Blood Vessel Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Biological Small-Caliber Artificial Blood Vessel Sales by Country (2021–2032)
3.5.3 Europe Biological Small-Caliber Artificial Blood Vessel Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Biological Small-Caliber Artificial Blood Vessel Market Facts & Figures by Region
3.6.1 Asia Pacific Biological Small-Caliber Artificial Blood Vessel Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Biological Small-Caliber Artificial Blood Vessel Sales by Region (2021–2032)
3.6.3 Asia Pacific Biological Small-Caliber Artificial Blood Vessel Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Biological Small-Caliber Artificial Blood Vessel Market Facts & Figures by Country
3.7.1 Latin America Biological Small-Caliber Artificial Blood Vessel Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Biological Small-Caliber Artificial Blood Vessel Sales by Country (2021–2032)
3.7.3 Latin America Biological Small-Caliber Artificial Blood Vessel Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Market Facts & Figures by Country
3.8.1 Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Sales by Country (2021–2032)
3.8.3 Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Biological Small-Caliber Artificial Blood Vessel Sales by Type (2021–2032)
4.1.1 Global Biological Small-Caliber Artificial Blood Vessel Sales by Type (2021–2026)
4.1.2 Global Biological Small-Caliber Artificial Blood Vessel Sales by Type (2027–2032)
4.1.3 Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Type (2021–2032)
4.2 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Type (2021–2032)
4.2.1 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Type (2021–2026)
4.2.2 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Type (2027–2032)
4.2.3 Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Type (2021–2032)
4.3 Global Biological Small-Caliber Artificial Blood Vessel Price by Type (2021–2032)
5 Segment by Application
5.1 Global Biological Small-Caliber Artificial Blood Vessel Sales by Application (2021–2032)
5.1.1 Global Biological Small-Caliber Artificial Blood Vessel Sales by Application (2021–2026)
5.1.2 Global Biological Small-Caliber Artificial Blood Vessel Sales by Application (2027–2032)
5.1.3 Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Application (2021–2032)
5.2 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Application (2021–2032)
5.2.1 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Application (2021–2026)
5.2.2 Global Biological Small-Caliber Artificial Blood Vessel Revenue by Application (2027–2032)
5.2.3 Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Application (2021–2032)
5.3 Global Biological Small-Caliber Artificial Blood Vessel Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Gore Medical
6.1.1 Gore Medical Company Information
6.1.2 Gore Medical Description and Business Overview
6.1.3 Gore Medical Biological Small-Caliber Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Gore Medical Biological Small-Caliber Artificial Blood Vessel Product Portfolio
6.1.5 Gore Medical Recent Developments/Updates
6.2 Terumo Corporation
6.2.1 Terumo Corporation Company Information
6.2.2 Terumo Corporation Description and Business Overview
6.2.3 Terumo Corporation Biological Small-Caliber Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Terumo Corporation Biological Small-Caliber Artificial Blood Vessel Product Portfolio
6.2.5 Terumo Corporation Recent Developments/Updates
6.3 Maquet
6.3.1 Maquet Company Information
6.3.2 Maquet Description and Business Overview
6.3.3 Maquet Biological Small-Caliber Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Maquet Biological Small-Caliber Artificial Blood Vessel Product Portfolio
6.3.5 Maquet Recent Developments/Updates
6.4 CryoLife
6.4.1 CryoLife Company Information
6.4.2 CryoLife Description and Business Overview
6.4.3 CryoLife Biological Small-Caliber Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CryoLife Biological Small-Caliber Artificial Blood Vessel Product Portfolio
6.4.5 CryoLife Recent Developments/Updates
6.5 LeMaitre Vascular
6.5.1 LeMaitre Vascular Company Information
6.5.2 LeMaitre Vascular Description and Business Overview
6.5.3 LeMaitre Vascular Biological Small-Caliber Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 LeMaitre Vascular Biological Small-Caliber Artificial Blood Vessel Product Portfolio
6.5.5 LeMaitre Vascular Recent Developments/Updates
6.6 Cook Medical
6.6.1 Cook Medical Company Information
6.6.2 Cook Medical Description and Business Overview
6.6.3 Cook Medical Biological Small-Caliber Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Cook Medical Biological Small-Caliber Artificial Blood Vessel Product Portfolio
6.6.5 Cook Medical Recent Developments/Updates
6.7 Boston Scientific
6.7.1 Boston Scientific Company Information
6.7.2 Boston Scientific Description and Business Overview
6.7.3 Boston Scientific Biological Small-Caliber Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Boston Scientific Biological Small-Caliber Artificial Blood Vessel Product Portfolio
6.7.5 Boston Scientific Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Company Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Biological Small-Caliber Artificial Blood Vessel Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Medtronic Biological Small-Caliber Artificial Blood Vessel Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Biological Small-Caliber Artificial Blood Vessel Industry Chain Analysis
7.2 Biological Small-Caliber Artificial Blood Vessel Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Biological Small-Caliber Artificial Blood Vessel Production Mode & Process Analysis
7.4 Biological Small-Caliber Artificial Blood Vessel Sales and Marketing
7.4.1 Biological Small-Caliber Artificial Blood Vessel Sales Channels
7.4.2 Biological Small-Caliber Artificial Blood Vessel Distributors
7.5 Biological Small-Caliber Artificial Blood Vessel Customer Analysis
8 Biological Small-Caliber Artificial Blood Vessel Market Dynamics
8.1 Biological Small-Caliber Artificial Blood Vessel Industry Trends
8.2 Biological Small-Caliber Artificial Blood Vessel Market Drivers
8.3 Biological Small-Caliber Artificial Blood Vessel Market Challenges
8.4 Biological Small-Caliber Artificial Blood Vessel Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Biological Small-Caliber Artificial Blood Vessel Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Biological Small-Caliber Artificial Blood Vessel Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Biological Small-Caliber Artificial Blood Vessel Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Biological Small-Caliber Artificial Blood Vessel Sales (Units) of Key Manufacturers (2021–2026)
 Table 5. Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Biological Small-Caliber Artificial Blood Vessel Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Biological Small-Caliber Artificial Blood Vessel Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Biological Small-Caliber Artificial Blood Vessel Average Price (K US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Biological Small-Caliber Artificial Blood Vessel, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Biological Small-Caliber Artificial Blood Vessel, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Biological Small-Caliber Artificial Blood Vessel, Product Types and Applications
 Table 12. Global Key Manufacturers of Biological Small-Caliber Artificial Blood Vessel, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Biological Small-Caliber Artificial Blood Vessel Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biological Small-Caliber Artificial Blood Vessel Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Biological Small-Caliber Artificial Blood Vessel Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Biological Small-Caliber Artificial Blood Vessel Sales by Region (Units), 2021–2026
 Table 18. Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Region (2021–2026)
 Table 19. Global Biological Small-Caliber Artificial Blood Vessel Sales by Region (Units), 2027–2032
 Table 20. Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Region (2027–2032)
 Table 21. Global Biological Small-Caliber Artificial Blood Vessel Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Region (2021–2026)
 Table 23. Global Biological Small-Caliber Artificial Blood Vessel Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Region (2027–2032)
 Table 25. North America Biological Small-Caliber Artificial Blood Vessel Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Biological Small-Caliber Artificial Blood Vessel Sales by Country (Units), 2021–2026
 Table 27. North America Biological Small-Caliber Artificial Blood Vessel Sales by Country (Units), 2027–2032
 Table 28. North America Biological Small-Caliber Artificial Blood Vessel Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Biological Small-Caliber Artificial Blood Vessel Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Biological Small-Caliber Artificial Blood Vessel Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Biological Small-Caliber Artificial Blood Vessel Sales by Country (Units), 2021–2026
 Table 32. Europe Biological Small-Caliber Artificial Blood Vessel Sales by Country (Units), 2027–2032
 Table 33. Europe Biological Small-Caliber Artificial Blood Vessel Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Biological Small-Caliber Artificial Blood Vessel Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Biological Small-Caliber Artificial Blood Vessel Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Biological Small-Caliber Artificial Blood Vessel Sales by Region (Units), 2021–2026
 Table 37. Asia Pacific Biological Small-Caliber Artificial Blood Vessel Sales by Region (Units), 2027–2032
 Table 38. Asia Pacific Biological Small-Caliber Artificial Blood Vessel Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Biological Small-Caliber Artificial Blood Vessel Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Biological Small-Caliber Artificial Blood Vessel Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Biological Small-Caliber Artificial Blood Vessel Sales by Country (Units), 2021–2026
 Table 42. Latin America Biological Small-Caliber Artificial Blood Vessel Sales by Country (Units), 2027–2032
 Table 43. Latin America Biological Small-Caliber Artificial Blood Vessel Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Biological Small-Caliber Artificial Blood Vessel Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Sales by Country (Units), 2021–2026
 Table 47. Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Sales by Country (Units), 2027–2032
 Table 48. Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Biological Small-Caliber Artificial Blood Vessel Sales (Units) by Type (2021–2026)
 Table 51. Global Biological Small-Caliber Artificial Blood Vessel Sales (Units) by Type (2027–2032)
 Table 52. Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Type (2021–2026)
 Table 53. Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Type (2027–2032)
 Table 54. Global Biological Small-Caliber Artificial Blood Vessel Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Biological Small-Caliber Artificial Blood Vessel Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Type (2021–2026)
 Table 57. Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Type (2027–2032)
 Table 58. Global Biological Small-Caliber Artificial Blood Vessel Price (K US$/Unit) by Type (2021–2026)
 Table 59. Global Biological Small-Caliber Artificial Blood Vessel Price (K US$/Unit) by Type (2027–2032)
 Table 60. Global Biological Small-Caliber Artificial Blood Vessel Sales (Units) by Application (2021–2026)
 Table 61. Global Biological Small-Caliber Artificial Blood Vessel Sales (Units) by Application (2027–2032)
 Table 62. Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Application (2021–2026)
 Table 63. Global Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Application (2027–2032)
 Table 64. Global Biological Small-Caliber Artificial Blood Vessel Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Biological Small-Caliber Artificial Blood Vessel Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Application (2021–2026)
 Table 67. Global Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Application (2027–2032)
 Table 68. Global Biological Small-Caliber Artificial Blood Vessel Price (K US$/Unit) by Application (2021–2026)
 Table 69. Global Biological Small-Caliber Artificial Blood Vessel Price (K US$/Unit) by Application (2027–2032)
 Table 70. Gore Medical Company Information
 Table 71. Gore Medical Description and Business Overview
 Table 72. Gore Medical Biological Small-Caliber Artificial Blood Vessel Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 73. Gore Medical Biological Small-Caliber Artificial Blood Vessel Product
 Table 74. Gore Medical Recent Developments/Updates
 Table 75. Terumo Corporation Company Information
 Table 76. Terumo Corporation Description and Business Overview
 Table 77. Terumo Corporation Biological Small-Caliber Artificial Blood Vessel Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 78. Terumo Corporation Biological Small-Caliber Artificial Blood Vessel Product
 Table 79. Terumo Corporation Recent Developments/Updates
 Table 80. Maquet Company Information
 Table 81. Maquet Description and Business Overview
 Table 82. Maquet Biological Small-Caliber Artificial Blood Vessel Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 83. Maquet Biological Small-Caliber Artificial Blood Vessel Product
 Table 84. Maquet Recent Developments/Updates
 Table 85. CryoLife Company Information
 Table 86. CryoLife Description and Business Overview
 Table 87. CryoLife Biological Small-Caliber Artificial Blood Vessel Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 88. CryoLife Biological Small-Caliber Artificial Blood Vessel Product
 Table 89. CryoLife Recent Developments/Updates
 Table 90. LeMaitre Vascular Company Information
 Table 91. LeMaitre Vascular Description and Business Overview
 Table 92. LeMaitre Vascular Biological Small-Caliber Artificial Blood Vessel Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 93. LeMaitre Vascular Biological Small-Caliber Artificial Blood Vessel Product
 Table 94. LeMaitre Vascular Recent Developments/Updates
 Table 95. Cook Medical Company Information
 Table 96. Cook Medical Description and Business Overview
 Table 97. Cook Medical Biological Small-Caliber Artificial Blood Vessel Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 98. Cook Medical Biological Small-Caliber Artificial Blood Vessel Product
 Table 99. Cook Medical Recent Developments/Updates
 Table 100. Boston Scientific Company Information
 Table 101. Boston Scientific Description and Business Overview
 Table 102. Boston Scientific Biological Small-Caliber Artificial Blood Vessel Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 103. Boston Scientific Biological Small-Caliber Artificial Blood Vessel Product
 Table 104. Boston Scientific Recent Developments/Updates
 Table 105. Medtronic Company Information
 Table 106. Medtronic Description and Business Overview
 Table 107. Medtronic Biological Small-Caliber Artificial Blood Vessel Sales (Units), Revenue (US$ Million), Price (K US$/Unit), and Gross Margin (2021–2026)
 Table 108. Medtronic Biological Small-Caliber Artificial Blood Vessel Product
 Table 109. Medtronic Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Biological Small-Caliber Artificial Blood Vessel Distributors List
 Table 113. Biological Small-Caliber Artificial Blood Vessel Customers List
 Table 114. Biological Small-Caliber Artificial Blood Vessel Market Trends
 Table 115. Biological Small-Caliber Artificial Blood Vessel Market Drivers
 Table 116. Biological Small-Caliber Artificial Blood Vessel Market Challenges
 Table 117. Biological Small-Caliber Artificial Blood Vessel Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Biological Small-Caliber Artificial Blood Vessel
 Figure 2. Global Biological Small-Caliber Artificial Blood Vessel Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Biological Small-Caliber Artificial Blood Vessel Market Share by Type: 2025 & 2032
 Figure 4. Autologous Cell-Derived Blood Vessels Product Picture
 Figure 5. Blood Vessels Derived From Non-Autologous Cells Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Biological Small-Caliber Artificial Blood Vessel Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Biological Small-Caliber Artificial Blood Vessel Market Share by Application: 2025 & 2032
 Figure 9. General Hospital
 Figure 10. Specialized Hospital
 Figure 11. Others
 Figure 12. Global Biological Small-Caliber Artificial Blood Vessel Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Biological Small-Caliber Artificial Blood Vessel Market Size (US$ Million), 2021–2032
 Figure 14. Global Biological Small-Caliber Artificial Blood Vessel Sales (Units), 2021–2032
 Figure 15. Global Biological Small-Caliber Artificial Blood Vessel Average Price (K US$/Unit), 2021–2032
 Figure 16. Biological Small-Caliber Artificial Blood Vessel Report Years Considered
 Figure 17. Biological Small-Caliber Artificial Blood Vessel Sales Share by Manufacturers in 2025
 Figure 18. Global Biological Small-Caliber Artificial Blood Vessel Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Biological Small-Caliber Artificial Blood Vessel Players: Market Share by Revenue in Biological Small-Caliber Artificial Blood Vessel in 2025
 Figure 20. Biological Small-Caliber Artificial Blood Vessel Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Biological Small-Caliber Artificial Blood Vessel Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Country (2021–2032)
 Figure 23. North America Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Country (2021–2032)
 Figure 24. United States Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Country (2021–2032)
 Figure 27. Europe Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Region (2021–2032)
 Figure 35. China Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Biological Small-Caliber Artificial Blood Vessel Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Biological Small-Caliber Artificial Blood Vessel Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Biological Small-Caliber Artificial Blood Vessel by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Biological Small-Caliber Artificial Blood Vessel by Type (2021–2032)
 Figure 55. Global Biological Small-Caliber Artificial Blood Vessel Price (K US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Biological Small-Caliber Artificial Blood Vessel by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Biological Small-Caliber Artificial Blood Vessel by Application (2021–2032)
 Figure 58. Global Biological Small-Caliber Artificial Blood Vessel Price (K US$/Unit) by Application (2021–2032)
 Figure 59. Biological Small-Caliber Artificial Blood Vessel Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS